Announcements Trials

Browse Landscape

Phase

Status

Completed 10 Terminated 3 Recruiting 2 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1 Gastrointestinal 1

Conditions

Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 139 Rituximab 115 Etoposide 77 Vincristine 75 Doxorubicin 62 Cytarabine 61 Dexamethasone 58 Prednisone 55 fludarabine 52 Methotrexate 46 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 42 Lenalidomide 37 Gemcitabine 35 Radiotherapy 29 Melphalan 27 pegaspargase 22 Prednisolone 22 Ifosfamide 22 fludarabine phosphate 20 Busulfan 20 Cisplatin 19 Bendamustine Hydrochloride 19 Asparaginase 18 Peripheral Blood Stem Cell Transplantation 17 ibrutinib 16 Decitabine 16 Carmustine 16 Mercaptopurine 15 Filgrastim 15 Oxaliplatin 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Diphenhydramine × Lymphoid × Clear all

NCT00324467 2021-07-22

LYTPET

British Columbia Cancer Agency

Phase 2 Unknown

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡